First Spire radiation oncology center to house Elekta's Versa HD system
LONDON /PRNewswire/ - One of the United Kingdom's largest private hospital providers, Spire Healthcare, recently announced an agreement with Elekta to help launch its new radiotherapy service. The partnership's opening project will be Spire's first cancer center in Bristol, for which Elekta will coordinate building construction and provide a comprehensive range of cancer management solutions, including the company's new Versa HD™ radiation therapy system.
Spire Healthcare is a major provider of cancer care in the UK, offering oncology services across 21 of its 38 sites. Although Spire presently refers patients needing radiotherapy to other providers, the country's need for additional radiation oncology capacity drove the hospital group's recent decision.
Ad Statistics
Times Displayed: 50213
Times Visited: 1424 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"Now is the right time for us to develop radiotherapy as a key part of the Spire services portfolio," says Neil McCullough, Spire's Business Development Director. "The National Radiotherapy Action Group [NRAG] reports that there is a significant and growing under-provision of radiotherapy services in the UK. As the population ages and cancer incidence increases, Spire is committed to offering a high quality, patient-focused, end-to-end cancer care pathway that will now include the very latest radiotherapy technology."
The new cancer center at Spire's Aztec West site in Bristol will be equipped with an array of advanced Elekta products, including MOSAIQ® Oncology Information System, and Elekta Planning Workspace, which includes Oncentra® 3D and Monaco® treatment planning systems and Atlas-Based Autosegmentation™ (ABAS).
The centerpiece of the Aztec West facility will be the new Versa HD linear accelerator. Versa HD offers the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of complex cancers that require extreme targeting precision. Treatment of challenging cases is enhanced by high-definition beam shaping, in addition to a groundbreaking High Dose Rate delivery mode.
"Spire is delighted to be working with Elekta in creating its first cancer center," McCullough says. "What impressed us most about Elekta was that they immediately recognized what we were trying to create and why. Their commitment to research and development will keep us at the forefront of technology advances and ensure that we can offer patients the very latest in radiotherapy techniques and delivery options.
